The emergence of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable interest within the weight loss community. This groundbreaking dual GIP and GLP-1 receptor medication appears to provide significant improvements in weight shedding compared to previous therapies. Preliminary clinical trials have shown substantial decreases in body ma